Skip to main content
CRISPR-based antiviral treatment of coronavirus infections

CRISPR-based antiviral treatment of coronavirus infections

Unmet Need The global market for antiviral drugs is a large one, topping $60B, and is getting larger due to the ongoing COVID-19 pandemic. Spurred on by a $3B investment from the U.S. government into…

Read More

RNA-based anticancer therapeutics

RNA-based anticancer therapeutics

Unmet Need Cancer has a major impact on society in the United States and across the world. More than a third of men and women will be diagnosed with cancer at some point during their…

Read More

Improving immune checkpoint therapies for cancer by inhibiting the PCSK9 protein

Improving immune checkpoint therapies for cancer by inhibiting the PCSK9 protein

Value Proposition Immune checkpoint inhibitor therapies are exciting new drugs for treatment of cancers. Despite their efficacy for certain cancers, immune checkpoint inhibitors only effective in 10-30% of cancer patients. Because of this, there is…

Read More

Induction of immunogenic cell death in cancer cells using modified ssRNAs

Induction of immunogenic cell death in cancer cells using modified ssRNAs

Value proposition Cancer immunotherapy is showing great promise against numerous cancer types in clinical trials. Consequently, this market is projected to rapidly grow to over $200 billion by 2021. Among the list of effective immunotherapies…

Read More

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us